Molecular Biology Enzymes Kits Reagents Market
Molecular Biology Enzymes, Kits & Reagents Market: North America to Remain Dominant in the Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2026)
- 2018-02-22
- REP-GB-6385
- 170 pages
-
An Incisive, In-depth Analysis on the Molecular Biology Enzymes Kits Reagents Market
This study offers a comprehensive, 360 degree analysis on the Molecular Biology Enzymes Kits Reagents market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Molecular Biology Enzymes Kits Reagents market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
COVID -19 : Impact Analysis
Request the coronavirus imapact analysis across industries and markets
Request Covid -19 ImpactThere is a rise in the prevalence of genetic disorders since the recent past, which in turn has driven adoption of molecular diagnostics. Key processes of molecular diagnostics such as epigenetics and polymerase chain reaction (PCR) require molecular biology enzymes, kits & reagents. With mounting incidences of genetic disorders on the back of growing geriatric population, demand for these enzymes and kits & reagents is expected to register a significant rise in the near future.
Manufacturers Focusing on Developing Advanced Products for Increasing their Product Portfolio
Several technological advancements have been made by manufacturers of molecular biology enzymes, kits & reagents, who are continuously focused toward the development of advanced products with an aim of increasing their product portfolio. These advanced products facilitate research processes with the provision of greater precision and enhanced efficiency. A great example of this is the launch of SMART Digest Kit by Thermo Fisher Scientific, Inc., specially designed for proteomic and biopharmaceutical applications. SMART Digest Kit enables generation of high-quality data, while curtailing the time required for sample preparation. Demand for molecular biology enzymes, kits & reagents is also expected to be propelled by heavy investments being made in research & development activities by pharmaceutical and biotechnology industries, along with the provision of reimbursements for molecular diagnostics.
Genetic data of an individual is considered to be highly confidential and sharing is strictly prohibited and governed by relevant regulatory bodies. Genome sequencing has aided in the identification & treatment of a wide variety of ailments. However, there is lack of effective tools required for securing genetic information of individuals, which is stored in cloud databases. This further creates threats of data thefts. This absence of high-end technology for storing genetic information will negatively impact adoption of molecular biology enzymes, kits & reagents.
A recently published report of Future Market Insights has slated a spectacular expansion for the global molecular biology enzymes, kits & reagents market between the assessment period 2017 and 2026. Worldwide sales of molecular biology enzymes, kits & reagents are likely to bring in approximately US$ 22,000 Mn revenues by 2026-end.
North America to Dominate Molecular Biology Enzymes, Kits & Reagents Market
North America held the largest revenue share of the global molecular biology enzymes, kits & reagents market in 2017, and is further anticipated to dominate the market through the assessment period. Factors contribution to the market expansion in North America include robust rise in research activities related to genomics, growing pharmaceutical sector in the region, and numerous awareness activities being undertaken by government and private institutions. However, regulatory norms associated with human cloning are likely to constrain the market expansion in North America.
Based on product type, kits & reagents will continue to be the leading revenue contributor to the market. Repeated utilization of kits & reagents in processes of genomics, coupled with their low costs has spurred their sales in biotechnology and pharmaceutical sector. Manufacturers are enabled to make advancements in kits & reagents on the back of their cost-effective production and growing adoption of molecular diagnostics.
Revenues from application of molecular biology enzymes, kits & reagents in sequencing are expected to remain the largest, on account of high implementation of sequencing-based medical treatment by hospitals in developed as well as developing nations. In addition, sequencing seeks widespread adoption in diagnosis and treatment of cancer in accordance with bioinformatics. Revenues from this application segment is likely to account for nearly 30% market share by 2026-end. Pharmaceutical and biotechnology companies are anticipated to remain the largest end-users of molecular biology enzymes, kits & reagents.
Competition Tracking
Leading players in the global market for molecular biology enzymes, kits & reagents are implementing strategies such as manufacturing capacity and geographic expansion. New product launches is also a key strategy adopted by the market players in order to enhance their share in this highly competitive market. Key companies profiled by the report that are actively underpinning growth of the market include Jena Bioscience GmbH, Takara Bio Inc., Roche Holdings, Inc., Illumina, Inc., Thermo Fisher Scientific Inc., Promega Corporation, KRISHGEN BioSystems, Agilent Technologies, Inc., Qiagen N.V., and Merck & Co Company.
Robust expansion of biotechnology and pharmaceutical industries across emerging countries is expected to pave significant opportunities for the development and advancements in molecular biology enzymes, kits & reagents. In addition, accelerating adoption of personalized medicines will further boost demand for molecular biology enzymes, kits & reagents. Adoption of these enzymes and their kits & reagents is expected to witness proliferation with technological advancements dedicated toward the development of innovative and more efficient products, in tandem with surging research and development investments being made by leading pharmaceutical and biotechnology companies.
Future Market Insights has published a new comprehensive research report titled, “Molecular Biology Enzymes, Kits & Reagents Market: Global Industry Analysis (2012-2016) & Opportunity Assessment (2017-2026)”. The report covers present market scenario as well as imparts future growth prospects of the molecular biology enzymes, kits & reagents market for the period between 2017 and 2026. The report also engulfs key drivers, hindrances, opportunities and trends that are affecting expansion of the global molecular biology enzymes, kits & reagents market. The report offers an overall picture of the global molecular biology enzymes, kits & reagents market, in order to help businesses seeking opportunities for making investments in the market.
Structure of the Report
The report provides an exhaustive synopsis of the global molecular biology enzymes, kits & reagents market, engulfing an executive summary that elucidates the core trends influencing the market expansion. This chapter also sheds light on impacts that the dynamics are likely to pose on growth of the market in the long run. The report also imparts figures appertaining to CAGRs from a historical and forecast point of view. An overview of the global molecular biology enzymes, kits & reagents market follows the executive summary, and issues a clear picture of the market’s scope to the report readers. The overview includes a concise market introduction succeeded by a formal definition of “molecular biology enzymes, kits & reagents”. Chapters subsequent to the overview elaborates several dynamics including driving factors, limitations and prospects being observed in the market through the forecast period. Meanwhile these chapter also inundate detailed insights related to the bottom line of enterprises, global economy and fiscal stimulus.
Market Taxonomy
A segmentation analysis offered in the report propounds forecasts on global molecular biology enzymes, kits & reagents market. Categorizing the market in terms of application, end-user, product type, and region. Analysis on Y-o-Y growth comparison, the market share comparison, and the revenue comparison coupled with relevant market numbers is offered in this chapter. Global market for molecular biology enzymes, kits & reagents has been regionally divided into Japan, Middle East & Africa, Europe, Asia-Pacific excluding Japan, North America, and Latin America.
|
Region |
Product Type |
End User |
Application |
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Competition Landscape
This analytical research report on the global molecular biology enzymes, kits & reagents market is a complete package, which includes intelligence on key participants underpinning the market expansion. In the last chapter of the report, which elucidates the competitive scenario of the market, strategies implemented by the market players, along with their product overview, company overview, key financials, key developments and SWOT analysis has been rendered exhaustively. In addition, region-wide spread of these market players, their future expansion plans, market shares, revenues, and mergers & acquisition activities between them have been described in detail in this concluding chapter of the report. An intensity map has been employed in the report to profile the market players situated across geographies.
Research Methodology
Credibility of the researched statistics and data is backed by the unique research methodology employed by the analysts at FMI, which ensures higher accuracy. FMI’s research report on the global molecular biology enzymes, kits & reagents market can assist its readers in gaining detailed insights on many different aspects governing the market around key regional segments included in the report. The report readers can further slate key strategies for tapping into vital revenue pockets and gaining benefits over the intensifying competition in the market. Information presented in the report has been scrutinized and monitored thoroughly by FMI’s industry experts. Figures and numbers offered in the report have also been validated by the analysts in order to facilitate strategic decision making for the report readers.
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.